Introduction
The amino acid L-arginine is a component of proteins and is involved in several metabolic pathways, including the urea cycle, the synthesis of creatine and the generation of nitric oxide [1] . In the last 2 years it has been established that arginine can also be decarboxylated, resulting in the formation of agmatine, 4-(aminobutyl)guanidine. The enzyme arginine decarboxylase was thought to be present only in bacteria and lower eukaryotes such as plants and parasitic worms. Recently, however, an enzymatic.activity that decarboxylates arginine has been described in brain [2] , kidney [3, 4] and several other mammalian tissues [3, 4] . This activity is associated with the mitochondrial fraction of cells [3, 4] . Homology-based polymerase chain reaction amplification has uncovered an mRNA in a number of mammalian tissues, especially the kidney, that is highly homologous to the bacterial biosynthetic (speA) gene product but not the biodegradative (adi) gene product [3] . Agmatine has been identified in extracts of rat kidney as the o-phthalaldehyde derivative by high performance liquid chromatography [4, 5] and as the hexafluoroacetylacetonate derivative by gas chromatographymass spectroscopy [Stickle D, Bohrer A, Berger R, Morrissey J, Klahr S, Turk J, unpublished]. The calculated concentration of agmatine in whole kidney extract is in the micromolar range. All of these studies strongly suggest that agmatine is produced within mammalian tissues and in particular the kidney. Agmatine appears to be an endogenous imidazoline receptor agonist [2, 6] and can also bind to a 2A -adrenergic receptors [2, 6] . Originally, it was described as a 'clonidine displacing substance' [2] ; however, more recent analysis suggests that agmatine does not closely mimic the central and systemic actions of clonidine • [7] . Agmatine does have a systemic vasodilatory effect and its administration can produce homologous tachyphylaxis without apparent heterologous tachyphylaxis Correspondence and offprint towards other vasodilatory substances [8] . This vasodilatory property of agmatine is in part due to its direct effect on endothelial cells. Agmatine was found to stimulate nitric oxide production by endothelial cells in culture [9] . This stimulation appears to be mediated by an increase in cytosolic calcium ion. Interestingly, the agmatine-mediated calcium transients were found to display homologous tachyphylaxis, but agmatine did not blunt the ability of noradrenaline to elicit a calcium transient [9] . This homologous-desensitization and lack of heterologous-desensitization of the calcium transients in vitro is reminiscent of the in vivo homologous tachyphylaxis to the vasodilatory effects of agmatine but not to other vasodilatory agents [8] . Agmatine may be further metabolized by diamine oxidase to guanidinobutyraldeyde in the kidney [4] . Diamine oxidase has an amino acid sequence identical to that of an 'amiloride binding protein' [10] and is inhibited by amiloride and amiloride analogues.
Imidazoline receptors and the kidney
Li et al. [2] and Piletz et al. [6] found that agmatine bound to imidazoline receptors. Pharmacologically, imidazoline receptors are divided into two groups based upon the binding of clonidine. The I, receptors have a high affinity (^ 10 nM) and I 2 receptors have a low affinity OlOOnM) for clonidine. Within the I 2 class there are I 2A receptors which are sensitive to amiloride and I 2B receptors which are insensitive to amiloride. Agmatine binds to both the I t and I 2 receptors [6] . Imidazoline receptors are influenced by potassium ion [11] while a 2 receptors are known to be modulated by sodium ion.
Kidney basolateral membranes contain imidazoline receptors of the I 2 class [11] [12] [13] [14] . This is true for membranes isolated from rat [12] , rabbit [11] , dog [13] , and human [14] kidneys. Membranes prepared from rat kidneys were also found to contain I t receptors [12] . In general, the different membrane preparations contain 90-570 fmol/mg protein of idazoxane binding sites sensitive to potassium ion and to guanine nucleotides [11] [12] [13] [14] . (Idazoxane is a pharmacological antagonist of imidazoline receptors.)
Mitochondria also possess imidazoline binding sites [15, 16] . These appear to be of the I 2A class. The imidazoline binding sites in mitochondria isolated from the kidney are more abundant than on basolateral membranes of the same organ and average 800-1200 fmol/mg protein [15, 16] . Mitochondria contain monoamine oxidase, which has an allosteric site equivalent to an I 2B receptor [17] .
Agmatine and kidney function
Given that the kidney expresses an mRNA for the enzyme that produces agmatine, and the kidney also contains agmatine as well as imidazoline receptors that bind agmatine, what are the effects of agmatine on renal function? In recent studies from the laboratory of Blantz et al, administration of agmatine into the renal interstitium and into the urinary space of surface glomeruli of Wistar-Fromter rats significantly increased the single nephron glomerular filtration rate (SNGFR) and absolute proximal reabsorption (APR) rate in surface nephrons [4] . In denervated kidneys microperfused in the same manner, agmatine also increased the SNGFR but not the APR. The I 2 receptor agonist BU-224 but not the Ij receptor agonist monoxidine had a similar effect on SNGFR [4] . The effects of agmatine were transient, possibly due to metabolism by diamine oxidase [4] .
Infusion of agmatine, monoxidine or clonidine into the renal artery of anaesthetized rats caused a significant increase in urine volume [18] . The infusion rate was such that none of the test compounds changed the systemic blood pressure of the animals. The effect of clonidine is dependent on an intact vasopressin system (V 2 receptor sensitive) and is due to an increase in free water clearance [18] . The increases in urine volume effected by agmatine and monoxidine, however, are secondary to an increase in osmolar clearance [18] . This finding is consonant with the imidazolinemediated inhibition of the Na + /H + exchanger in isolated renal proximal tubule cells [19] .
A major effect of agmatine may be to inhibit the calcium-sensitive nitric oxide synthase within the kidney [3] . It is possible that this effect protects the cell from self-destruction by preventing nitric oxide from inhibiting mitochondrial function [3] . This raises the interesting possibility that agmatine functions in an autocrine role to guard against overproduction of nitric oxide while functioning in a paracrine role in adjacent cells to produce nitric oxide. The immediate metabolite, guanidinobutyraldehyde, also inhibits nitric oxide formation [20] .
Agmatine and imidazoline receptors in renal disease
The characterization of agmatine as a meaningful biomolecule in kidney function is very recent. The Nephrol Dial Transplant (1996) 11: Editorial Comments involvement of this imidazoline receptor agonist in renal disease awaits detailed examination. In one study, however, agmatine did blunt collagen accumulation in genetically diabetic mice [21] . The total collagen content was reduced while the acid solubility of this collagen increased in the db/db mouse kidney. The precise mechanism for this effect of agmatine is unknown but is thought to involve decreased crosslinking of collagen [21] . We also cannot exclude the possibility that some of the effects of arginine administration in renal disease are not mediated through agmatine [22, 23] .
Smyth and co-workers have found that the natriuretic and diuretic responses to 2,6-dimethyl clonidine [24] , monoxidine or rilmenidine [25] are blunted in the one-kidney, one-clip model of hypertension in the rat. These pharmacological agents operate through imidazoline receptors. The renal effect of 2,6-dimethyl clonidine is antagonized by idazoxan [24] . Furthermore, the number of renal imidazoline receptor sites in the one-kidney, one-clip animals was significantly reduced, with no significant change in the number of rauwolscine binding a 2 -receptor sites [24] .
Although not yet tested in this rat model, agmatine and monoxidine have similar natriuretic and diuretic effects in normal rats [18] .
Biological significance of agmatine
Agmatine is an endogenous imidazoline receptor agonist and can bind to a 2 -receptors present in the kidney. This decarboxylation product of arginine can regulate the nitric oxide pathway of arginine metabolism. Therefore, agmatine may have direct receptormediated and secondary nitric oxide-mediated effects on renal function. We cannot exclude the possibility that agmatine might also exert effects by non-receptordependent mechanisms. Evaluation of the role of agmatine in kidney physiology must include precise determinations of the effects that agmatine brings about through imidazoline and a 2 -adrenergic receptors. A potential functional role of metabolic products of agmatine also deserves attention.
Introduction
Systemic lupus erythemathosus (SLE) is an autoimmune disease characterized by the formation of antinuclear autoantibodies especially against doublestranded (ds) DNA [1, 2] . Although initially it was thought that the formation of these autoantibodies was due to polyclonal B cell activation, it is now clear that the disease arises as a result of an (auto-) antigen driven response, since somatic mutations, clonal expansion and IgG class switches occur. There is fair evidence that anti-dsDNA antibodies are important in the initiation of tissue lesions especially lupus glomerulonephritis. Because of this pathogenic role, numerous attempts have been made to induce these anti-dsDNA antibodies by immunization of dsDNA from various sources, either alone or complexed to proteins. These experiments have revealed that DNA is poorly immunogenic. But if the formation of autoantibodies in SLE is antigen driven and DNA is not the driving antigen, are there other candidates?
In recent years the nucleosome has been put forward as a major candidate for the autoantigen that drives the autoimmune response in SLE [3, 4] . In this editorial comment we will review these data and also discuss the role of nucleosomes in the pathogenesis of lupus nephritis.
Immunogenicity of nucleosomes
Nucleosomes consists of a 146 bp segment of DNA wrapped, in two superhelical turns, around an octameric core complex containing four pairs of the histone proteins H2A, H2B, H3, and H4. DNA within the nucleosome is responsible for clustered negative charges. On the other hand, the amino-terminal 20-30 amino acids of H2A, H2B, H3 and H4, which are exposed on the surface, are strongly positively charged. Nucleosomes can act as polyclonal B cell activators, which might be relevant in the initiation of disease. But more importantly, since lupus is an antigen-driven
